Urchin-Like Mesoporous Silica Nanoparticles Lower Intraocular Pressure through PARP1 Inhibition

Elevated intraocular pressure (IOP) drives glaucoma progression, yet durable control is limited by incomplete mechanistic targeting and inefficient anterior-segment drug delivery. Here, we identify poly(ADP-ribose) polymerase 1 (PARP1) hyperactivation as a redox-sensitive control node governing conventional outflow failure. In human trabecular meshwork and Schlemm’s canal tissues, upregulated PARP1, following oxidative stress, enforces nuclear retention of the ataxia telangiectasia mutated–NF-κB essential modulator (ATM–NEMO) complex. This suppresses cytoplasmic protein kinase B–endothelial nitric oxide synthase (AKT–eNOS) signaling and depletes intracellular nicotinamide adenine dinucleotide (NAD+), effectively coupling DNA damage responses to nitric oxide deficiency and metabolic collapse. To reprogram this dual enzymatic–metabolic disturbance, we engineer a geometry-enhanced, pH-gated urchin-like mesoporous nanoplatform (hereafter denoted PUON@NMOF) that enables spatially segregated codelivery of the PARP1 inhibitor niraparib and the NAD+ precursor nicotinamide mononucleotide. The spiny nanoarchitecture enhances corneal adhesion and trans-epithelial transport, while the metal–organic framework (MOF) shell provides switchable release under mildly acidic microenvironments. Topical administration achieves preferential accumulation in outflow tissues, restores NAD+ pools, reactivates AKT–eNOS signaling and produces synergistic IOP reduction across distinct glaucoma models. These findings define the redox–PARP1 axis as a druggable vulnerability and establish materials-enabled dual-pathway correction as a strategy for precision modulation of outflow biomechanics.

Authors

Institutions

Publication Details

Journal
ACS Nano
Published
2026-11-21
DOI
https://doi.org/10.1021/acsnano.6c12092
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Urchin-Like Mesoporous Silica Nanoparticles Lower Intraocular Pressure through PARP1 Inhibition

Wenpei Fan, He Bai, Qunqun Bao, Yuan Lei et al.
ACS Nano
Glaucoma and retinal disorders
article

Urchin-Like Mesoporous Silica Nanoparticles Lower Intraocular Pressure through PARP1 Inhibition

Wenpei Fan, He Bai, Qunqun Bao, Yuan Lei, Chao Xing, Jiamin Liu, Xinghuai Sun, Maomao Song, Ming Chen
article en

Abstract

Elevated intraocular pressure (IOP) drives glaucoma progression, yet durable control is limited by incomplete mechanistic targeting and inefficient anterior-segment drug delivery. Here, we identify poly(ADP-ribose) polymerase 1 (PARP1) hyperactivation as a redox-sensitive control node governing conventional outflow failure. In human trabecular meshwork and Schlemm’s canal tissues, upregulated PARP1, following oxidative stress, enforces nuclear retention of the ataxia telangiectasia mutated–NF-κB essential modulator (ATM–NEMO) complex. This suppresses cytoplasmic protein kinase B–endothelial nitric oxide synthase (AKT–eNOS) signaling and depletes intracellular nicotinamide adenine dinucleotide (NAD+), effectively coupling DNA damage responses to nitric oxide deficiency and metabolic collapse. To reprogram this dual enzymatic–metabolic disturbance, we engineer a geometry-enhanced, pH-gated urchin-like mesoporous nanoplatform (hereafter denoted PUON@NMOF) that enables spatially segregated codelivery of the PARP1 inhibitor niraparib and the NAD+ precursor nicotinamide mononucleotide. The spiny nanoarchitecture enhances corneal adhesion and trans-epithelial transport, while the metal–organic framework (MOF) shell provides switchable release under mildly acidic microenvironments. Topical administration achieves preferential accumulation in outflow tissues, restores NAD+ pools, reactivates AKT–eNOS signaling and produces synergistic IOP reduction across distinct glaucoma models. These findings define the redox–PARP1 axis as a druggable vulnerability and establish materials-enabled dual-pathway correction as a strategy for precision modulation of outflow biomechanics.

ACS Nano
Shanghai Medical College of Fudan University (CN), China Pharmaceutical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Fudan University (CN), Gaozhou People's Hospital (CN)
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon